Spike protein (S protein) of SARS-CoV-2 mediates host cell entry via angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), targeting of which could serve as an important therapeutic strategy for COVID-19. This evidence concerns the gene TMPRSS2 and COVID-19.